Thermo Fisher Scientific’s Martin Danielson talks to PME; Celebrating the 2025 PMEAs; Redefining the prostate cancer landscape
ESMO celebrates 50 years of focusing on oncology research; Improving cardiovascular disease therapy; Global pharma pricing impact on supply chains
Explore the 'Patient Metro' journey, the pillars of Alzheimer's blood testing, and how to de-risk clinical trials with platelet analysis for improved healthcare outcomes.
Will data and AI transform launch excellence? The impact of us tariffs on healthcare and life sciences; The power of digital and AI engineering
Full coverage of this year’s Communiqué Awards; The importance of patient engagement; Cannes Lions 2025 highlights
Communicating with HCPs through AI; ASCO 2025 highlights; The impact of US tariffs on pharma manufacturing
Rising to meet the challenges of clinical trials; Accelerating access to rare disease treatments; Maximising the potential of AI in pharma
How HCPs and patients are partnering to transform care; The impact of MS on ageing patients; AI in healthcare
PMLiVE’s Top Pharma List is live!; Omnichannel – breaking down the barriers; Rare diseases – improving patient access
Achieving inclusivity for minorities in clinical trials; Why local knowledge is key for pharmacovigilance; EU vs US trends in clinical trials
Avalere Health’s Amar Urhekar on his career path; Insights from ASH 2024; The science behind gene-silencing technology
Sanofi’s John Forni on the escalating challenges of treating COPD; The need for a human touch in an AI world; PMGroup celebrates the 24th PMEAs!
The explosive growth of Gen AI; Liberating patient pathways; Closing health equity gaps
Boehringer Ingelheim’s Ulrike Graefe-Mody on her career path; Driving launch excellence; Top trends coming out of ESMO 2024
The challenges of environmental sustainability; ‘Causes That Count, Health’ report; Rethinking neurodegeneration
Merck’s Doina Ionescu on her professional journey; Full coverage of Communiqué 2024; Omnichannel opportunities
GSK’s Jack Harris on innovation in oncology; Harnessing creativity in a digital age; Sustainability in pharma
Interview with Ipsen’s Ioana Parsons on her new role; Celebrating comms excellence; Getting trial diversity right
Astellas' Marci English on managing the menopause; Clinigen’s Lorna Pender on treating rare diseases; the science behind behaviour change
Interview with Sanofi’s Rippon Ubhi on her new role; Optimising MS care and patient outcomes; Overcoming pharma web strategy challenges
Diversity, equity and inclusion in medical research; Marking International Day of Women and Girls in Science; Incentivising innovation in antibiotics
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
Thought Leadership, 18 December 2025
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
Thought Leadership, 27 November 2025
PRECISION AQ - From insight to impact: strengthening stakeholder engagement across the patient journey
Thought Leadership, 30 October 2025
Aspire Pharma – enhancing the patient experience through stakeholder engagement. ‘Equipping HCPs with the right tools, resources and knowledge is essential in removing barriers to care’
Thought Leadership, 30 October 2025
The evolutionary lessons for Bayer’s management restructure
Roche and Ascidian agree to $1.8bn neurological disease partnership
Researchers identify new major cause of inflammatory bowel disease
Collecting the right data in the right way for the right reasons
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
Roche and Ascidian agree to $1.8bn neurological disease partnership
Researchers identify new major cause of inflammatory bowel disease
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
The evolutionary lessons for Bayer’s management restructure
Collecting the right data in the right way for the right reasons
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
Creativity cages - The surprising way to think out of the box
The hidden strength of teams: how collaboration can build resilience
In the world of pharma, celebrating the thrill of a new product launch comes naturally. What’s harder, and often overlooked, is managing the portfolio that quietly sustains the business long after the fanfare fades.
Picking your omnichannel direction requires a disciplined, scientific approach
Features, 18 December 2025
Across almost every sector, brands are multiplying their investment in creativity
Features, 18 December 2025
Across almost every sector, brands are multiplying their investment in creativity
Features, 27 November 2025
Picking your omnichannel direction requires a disciplined, scientific approach
Features, 27 November 2025
‘Patient engagement is both a process and a behaviour throughout the drug life cycle’
Communique - Marketing & Comms, 18 December 2025
‘Patient engagement is both a process and a behaviour throughout the drug life cycle’
Communique - Marketing & Comms, 27 November 2025
PME October 2025 - Appointments
Appointments & Recruitment, 30 October 2025
PME October 2025 Appointments
Appointments & Recruitment, 30 October 2025
Pharmaceutical industry news, articles, jobs, reports, advice and services
